• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Fecal Microbiota-based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C. difficile Infection.基于粪便微生物群的疗法与粪便微生物群移植预防艰难梭菌反复感染的比较
Clin Gastroenterol Hepatol. 2025 Sep 8. doi: 10.1016/j.cgh.2025.08.029.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌（艰难梭菌）。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Fecal microbiota live - jslm (Rebyota™/RBL) for management of recurrent infection.用于治疗复发性感染的粪便微生物群活菌制剂-jslm（Rebyota™/RBL）
Future Microbiol. 2024;19(14):1243-1251. doi: 10.1080/17460913.2024.2364583. Epub 2024 Jul 11.
4
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.AGA 临床实践指南：基于粪便微生物群的疗法治疗特定胃肠道疾病。
Gastroenterology. 2024 Mar;166(3):409-434. doi: 10.1053/j.gastro.2024.01.008.
5
Microbiota restoration therapies for recurrent infection reach an important new milestone.用于复发性感染的微生物群恢复疗法达到了一个重要的新里程碑。
Therap Adv Gastroenterol. 2024 May 24;17:17562848241253089. doi: 10.1177/17562848241253089. eCollection 2024.
6
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection.用于治疗艰难梭菌感染的活体生物治疗药物的不断演变格局。
Indian J Gastroenterol. 2025 Apr;44(2):129-141. doi: 10.1007/s12664-024-01717-9. Epub 2025 Jan 16.
7
Fecal Microbiome Transplantation for Recurrent CDI: Treatment Efficacy and Safety with Oral Capsules.粪便微生物群移植治疗复发性艰难梭菌感染：口服胶囊的治疗效果与安全性
J Gastrointestin Liver Dis. 2025 Jun 28;34(2):199-204. doi: 10.15403/jgld-5990.
8
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.复发性艰难梭菌感染：当前的临床管理及基于微生物群的治疗方法
BioDrugs. 2023 Nov;37(6):757-773. doi: 10.1007/s40259-023-00617-2. Epub 2023 Jul 26.
9
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA®) for Preventing Recurrent Clostridioides difficile Infection.给予粪便微生物群制剂Live-jslm（REBYOTA®）预防艰难梭菌反复感染后微生物组和代谢组的恢复
J Infect Dis. 2024 Aug 22. doi: 10.1093/infdis/jiae418.
10
Fecal microbiota transplantation as a therapeutic modality for recurrent infection: reviewing efficacy, safety, mechanisms of action, and outcomes.粪便微生物群移植作为复发性感染的一种治疗方式：疗效、安全性、作用机制及结果综述
Ann Med Surg (Lond). 2025 Jul 25;87(9):5829-5850. doi: 10.1097/MS9.0000000000003649. eCollection 2025 Sep.

本文引用的文献

1
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.在复发性艰难梭菌感染的成人中作为研究用微生物组治疗药物的 SER-109 的安全性和耐受性：一项 3 期、开放标签、单臂试验。
JAMA Netw Open. 2023 Feb 1;6(2):e2255758. doi: 10.1001/jamanetworkopen.2022.55758.
2
Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.艰难梭菌感染粪便微生物群移植的有效性和安全性：来自一项5344例患者队列研究的结果
Gastroenterology. 2022 Jul;163(1):319-322. doi: 10.1053/j.gastro.2022.03.051. Epub 2022 Apr 7.
3
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.欧洲临床微生物学和传染病学会：成人艰难梭菌感染治疗指南的 2021 年更新。
Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21. doi: 10.1016/j.cmi.2021.09.038. Epub 2021 Oct 20.
4
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.ACG 临床指南：艰难梭菌感染的预防、诊断和治疗。
Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147. doi: 10.14309/ajg.0000000000001278.
5
Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.复发性艰难梭菌感染粪便微生物群移植对照试验中低治愈率：系统评价和荟萃分析。
Clin Infect Dis. 2019 Apr 8;68(8):1351-1358. doi: 10.1093/cid/ciy721.
6
Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope.通过结肠镜直接给予捐赠粪便治疗复发性艰难梭菌相关性腹泻。
Am J Gastroenterol. 2000 Nov;95(11):3283-5. doi: 10.1111/j.1572-0241.2000.03302.x.

Fecal Microbiota-based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C. difficile Infection.

作者信息

Nguyen Larry, Feuerstadt Paul, Allegretti Jessica R, Axelrad Jordan

机构信息

NYU Grossman School of Medicine, Department of Medicine, New York, New York.

Yale School of Medicine, Attending Gastroenterologist, PACT Gastroenterology Center, Hamden, Connecticut.

出版信息

Clin Gastroenterol Hepatol. 2025 Sep 8. doi: 10.1016/j.cgh.2025.08.029.

DOI:10.1016/j.cgh.2025.08.029
PMID:40930304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12433683/
Abstract
摘要